Why Harmony Biosciences (HRMY) is Poised to Beat Earnings Estimates Again

Core Insights - Harmony Biosciences Holdings, Inc. has consistently beaten earnings estimates, with an average surprise of 23.53% over the last two quarters [1][5] - For the most recent quarter, the company reported earnings of $0.59 per share against an expectation of $0.78, resulting in a surprise of 32.20% [2] - The previous quarter saw Harmony Biosciences exceed the consensus estimate of $0.74 per share by reporting $0.85, achieving a surprise of 14.86% [2] Earnings Estimates and Predictions - Recent estimates for Harmony Biosciences have been increasing, indicating a positive outlook for future earnings [5] - The Zacks Earnings ESP for the company is currently +19.75%, suggesting analysts are optimistic about its earnings prospects [8] - A positive Earnings ESP combined with a Zacks Rank of 2 (Buy) indicates a strong possibility of another earnings beat [8] Statistical Insights - Stocks with a positive Earnings ESP and a Zacks Rank of 3 (Hold) or better have a nearly 70% chance of producing a positive surprise [6] - The Zacks Earnings ESP compares the Most Accurate Estimate to the Zacks Consensus Estimate, reflecting the latest analyst revisions [7] - It is crucial to check a company's Earnings ESP before quarterly releases to enhance the likelihood of successful investment decisions [10]